ATE307676T1 - Eine verpackungseinheit für die medikamentverabreichung in der olfaktorischen region - Google Patents

Eine verpackungseinheit für die medikamentverabreichung in der olfaktorischen region

Info

Publication number
ATE307676T1
ATE307676T1 AT98930657T AT98930657T ATE307676T1 AT E307676 T1 ATE307676 T1 AT E307676T1 AT 98930657 T AT98930657 T AT 98930657T AT 98930657 T AT98930657 T AT 98930657T AT E307676 T1 ATE307676 T1 AT E307676T1
Authority
AT
Austria
Prior art keywords
pharmaceutical preparation
drug administration
olfactory region
packaging unit
human
Prior art date
Application number
AT98930657T
Other languages
English (en)
Inventor
Sveinbjoern Gizurarson
Original Assignee
Sveinbjoern Gizurarson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36699744&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE307676(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sveinbjoern Gizurarson filed Critical Sveinbjoern Gizurarson
Application granted granted Critical
Publication of ATE307676T1 publication Critical patent/ATE307676T1/de

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
    • B05B11/00—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use
    • B05B11/01—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use characterised by the means producing the flow
    • B05B11/02—Membranes or pistons acting on the contents inside the container, e.g. follower pistons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
    • B05B1/00—Nozzles, spray heads or other outlets, with or without auxiliary devices such as valves, heating means
    • B05B1/02—Nozzles, spray heads or other outlets, with or without auxiliary devices such as valves, heating means designed to produce a jet, spray, or other discharge of particular shape or nature, e.g. in single drops, or having an outlet of particular shape
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
    • B05B11/00—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use
    • B05B11/0005—Components or details
    • B05B11/0027—Means for neutralising the actuation of the sprayer ; Means for preventing access to the sprayer actuation means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/08—Inhaling devices inserted into the nose
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/70—Nanostructure
    • Y10S977/788—Of specified organic or carbon-based composition
    • Y10S977/797—Lipid particle
    • Y10S977/798—Lipid particle having internalized material
    • Y10S977/799—Containing biological material
    • Y10S977/801—Drug
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Containers And Plastic Fillers For Packaging (AREA)
AT98930657T 1997-07-01 1998-07-01 Eine verpackungseinheit für die medikamentverabreichung in der olfaktorischen region ATE307676T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IS4516A IS4516A (is) 1997-07-01 1997-07-01 Nýtt lyfjaform
PCT/DK1998/000297 WO1999001229A1 (en) 1997-07-01 1998-07-01 A method for administration of active substances to the olfactory region

Publications (1)

Publication Number Publication Date
ATE307676T1 true ATE307676T1 (de) 2005-11-15

Family

ID=36699744

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98930657T ATE307676T1 (de) 1997-07-01 1998-07-01 Eine verpackungseinheit für die medikamentverabreichung in der olfaktorischen region

Country Status (10)

Country Link
US (1) US6647980B1 (de)
EP (1) EP0991479B1 (de)
AT (1) ATE307676T1 (de)
AU (1) AU739893B2 (de)
CA (1) CA2298596A1 (de)
DE (1) DE69832070T2 (de)
DK (1) DK0991479T3 (de)
ES (1) ES2255165T3 (de)
IS (1) IS4516A (de)
WO (1) WO1999001229A1 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7033598B2 (en) 1996-11-19 2006-04-25 Intrabrain International N.V. Methods and apparatus for enhanced and controlled delivery of a biologically active agent into the central nervous system of a mammal
DE10004547A1 (de) * 2000-02-02 2001-08-09 Liedtke Pharmed Gmbh Verfahren zur selektiven Verabreichung zentralnervös aktiver Stoffe
US6853858B2 (en) * 2000-05-08 2005-02-08 Brainsgate, Ltd. Administration of anti-inflammatory drugs into the central nervous system
ES2284831T3 (es) * 2001-02-08 2007-11-16 Nasaleze Patents Limited Aparato para dispensar material en polvo.
KR20040095232A (ko) * 2002-02-25 2004-11-12 라이프자트로운 에이치에프 흡수촉진제
JP2005524494A (ja) 2002-05-09 2005-08-18 グラクソ　グループ　リミテッド 流体分配装置
US20040039352A1 (en) * 2002-06-28 2004-02-26 Paul Bergeson Nasal dosing device
US20050070460A1 (en) 2003-08-05 2005-03-31 3M Innovative Properties Company Infection prophylaxis using immune response modifier compounds
WO2005044354A1 (en) 2003-11-03 2005-05-19 Glaxo Group Limited A fluid dispensing device
GB0405477D0 (en) 2004-03-11 2004-04-21 Glaxo Group Ltd A fluid dispensing device
US20060207596A1 (en) * 2005-03-18 2006-09-21 Fairfield Clinical Trials, Llc Device and method for delivery of combination nasal medication
GB0507224D0 (en) 2005-04-09 2005-05-18 Glaxo Group Ltd A fluid dispensing device
EP1960022A1 (de) * 2005-11-29 2008-08-27 Alza Corporation Nasale abgabevorrichtung zur abgabe einer substanz in die olfaktorische region
EP3546000A1 (de) * 2006-01-19 2019-10-02 Optinose AS Nasale verabreichung
GB0604444D0 (en) 2006-03-06 2006-04-12 Optinose As Nasal devices
GB2438834A (en) * 2006-06-08 2007-12-12 Optinose As Intranasal protein administration
US20080228162A1 (en) * 2007-03-16 2008-09-18 Medlmmune Vaccines, Inc. Single-use ampoule
GB2448193A (en) 2007-04-05 2008-10-08 Optinose As Nasal delivery device
CA2685706C (en) * 2007-05-04 2012-07-24 The Procter & Gamble Company Antimicrobial compositions, products, and methods of use
EP2247330B1 (de) * 2008-02-07 2017-09-20 The University of Washington Ringförmige aerosolvorrichtung
CN102427847A (zh) 2009-05-19 2012-04-25 爱德华N.·勒纳 将生物学活性物质增强多重递送至有机体并预防局部刺激的设备和方法
EP3679971B1 (de) * 2011-03-03 2022-07-27 Impel Pharmaceuticals Inc. Vorrichtung für nasale wirkstofffreisetzung
JP6645735B2 (ja) 2011-05-09 2020-02-14 インペル ニューロファーマ インコーポレイテッド 鼻薬送達用ノズル
WO2014179228A1 (en) 2013-04-28 2014-11-06 Impel Neuropharma Inc. Medical unit dose container
GB201308679D0 (en) 2013-05-14 2013-06-26 3M Innovative Properties Co Actuator for an inhaler
CN108601916B (zh) 2015-09-10 2021-07-09 英倍尔药业股份有限公司 直列式鼻部递送装置
WO2019104192A1 (en) 2017-11-21 2019-05-31 Impel Neuropharma, Inc. Intranasal device with inlet interface
US11571532B2 (en) 2017-11-21 2023-02-07 Impel Pharmaceuticals Inc. Intranasal device with dip tube
BR112020013744A8 (pt) 2018-01-05 2022-10-18 Impel Neuropharma Inc Dispensação intranasal de di-hidroergotamina por dispositivo olfativo de precisão
WO2019136308A1 (en) 2018-01-05 2019-07-11 Impel Neuropharma, Inc. Intranasal delivery of olanzapine by precision olfactory device
KR20210034047A (ko) 2018-07-19 2021-03-29 임펠 뉴로파마 인코포레이티드 파킨슨 병 치료를 위한 레보도파 및 도파 데카르복실라아제 저해제의 기도 전달
WO2020142206A1 (en) 2019-01-03 2020-07-09 Impel Neuropharma, Inc. Nasal drug delivery device
WO2020236658A1 (en) 2019-05-17 2020-11-26 Impel Neuropharma, Inc. Single-use nasal delivery device
BR112022004497A2 (pt) * 2019-09-13 2022-05-31 Janssen Pharmaceuticals Inc Administração intranasal de escetamina
FR3120534B1 (fr) * 2021-03-09 2023-06-30 Aptar France Sas Tête de distribution nasale de produit fluide et dispositif comportant une telle tête

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4054622A (en) * 1970-11-03 1977-10-18 Lester Victor E Combination nebulizer and humidifier
US3762409A (en) * 1970-11-03 1973-10-02 V Lester Nebulizer
CH539556A (de) * 1971-03-16 1973-07-31 Ciba Geigy Ag Applikator zur dosierten Ausgabe einer Flüssigkeit
US3961756A (en) * 1975-02-10 1976-06-08 National Chemsearch Corporation Adjustable-spray mechanism
US4961727A (en) * 1988-11-16 1990-10-09 Beard Walter C Dispensing package
US5116315A (en) * 1989-10-03 1992-05-26 Hemaedics, Inc. Biological syringe system
WO1991007947A1 (en) 1989-12-05 1991-06-13 Ramsey Foundation Neurologic agents for nasal administration to the brain
DE4016126A1 (de) * 1990-04-17 1991-10-24 Coster Tecnologie Speciali Spa Vorrichtung zur transnasalen oder oralen verabreichung von medikamenten o. dgl.
WO1993002729A1 (en) * 1990-07-12 1993-02-18 Habley Medical Technology Corporation Super atomizing nonchlorinated fluorocarbon medication inhaler
DK198591D0 (da) * 1991-12-10 1991-12-10 Novo Nordisk As Apparat
US5525329A (en) 1992-05-21 1996-06-11 The Johns Hopkins University Inhibition of phosphodiesterase in olfactory mucosa
GB9405952D0 (en) * 1994-03-25 1994-05-11 Zeneca Ltd Aqueous ophthalmic sprays
FR2732318B1 (fr) * 1995-03-31 1997-04-25 Oreal Ditributeur aerosol a deux buses de pulverisation
GB9519692D0 (en) * 1995-09-27 1995-11-29 Quillin Helen Atomising nozzle
AU7669496A (en) 1995-11-03 1997-05-22 University Of Kentucky Method for the intranasal administration of l-dopa prodrugs
US5921233A (en) * 1997-09-04 1999-07-13 Pincgold Llc Liquid dispenser assembly particularly for medical applications

Also Published As

Publication number Publication date
EP0991479A1 (de) 2000-04-12
ES2255165T3 (es) 2006-06-16
IS4516A (is) 1999-01-02
EP0991479B1 (de) 2005-10-26
DK0991479T3 (da) 2006-03-13
AU8102298A (en) 1999-01-25
WO1999001229A1 (en) 1999-01-14
US6647980B1 (en) 2003-11-18
CA2298596A1 (en) 1999-01-14
AU739893B2 (en) 2001-10-25
DE69832070D1 (de) 2005-12-01
DE69832070T2 (de) 2006-07-13

Similar Documents

Publication Publication Date Title
DE69832070D1 (de) Eine Verpackungseinheit für die Medikamentverabreichung in der olfaktorischen Region
Tartara et al. Vigabatrin in the treatment of epilepsy: a double‐blind, placebo‐controlled study
NO20001087D0 (no) Medikament for forlengelse av muskelfunksjon eller behandling av muskelforstyrrelser eller -sykdommer
DE69527842D1 (de) Oral anzuwendendes flüssiges arzneimittel enthaltend alendronat
NL990012I1 (nl) Geneesmiddelen die salmeterol en fluticason bevatten.
KR960700742A (ko) 아토피성질환 치료약(atopic disease remedy)
GEP20043216B (en) Orally Administered Controlled Drug Delivery System
EP1242013A4 (de) Bukkale transmukosale arzneidarreichung unter verwendung einer festen lösung
DE69518334D1 (de) Pharmazeutische aerosol welche mindestens ein zucker enthält
ATE145819T1 (de) Inhalierbare arzneimittel
HUP9802828A2 (hu) Belélegezhető vivőanyag szabályozott hatóanyag-leadású gyógyszerkészítményekhez
NO924209L (no) Doseringsform for tilfoersel av et antiparkinsonmiddel
BR9802537A (pt) Método para anestesiar um paciente humano antes de cirurgias de porte dose unitária e sistema farmacêutico para administração
NO890186L (no) Fremgangsmaate for fremstilling av en avgivelses- og/ellerdoseringsform for legemiddelaktive stoffer.
KR950028767A (ko) 피부통과 투약을 위한 신규의 약제학적 투여 형태
KR20010021505A (ko) 발기 부전을 치료하기 위한 요힘빈 및 아르기닌 함유 약제
KR930019224A (ko) 유산 위험 치료제
AR006202A1 (es) Usos de antagonista ige para preparar un medicamento util para el tratamiento de las enfermedades alergicas y composiciones que los contiene
HUP0301408A2 (hu) Szulodexid alkalmazása diabetikus vesebetegség kezelésére szolgáló orális gyógyszerkészítmény előállítására
CA3178758A1 (en) Treatment of adjustment disorders
KR920700041A (ko) 치료화합물과 그의 조성 및 용도
Schweizer Once-a-day control of panic disorder: Evidence from a placebo-controlled trial of alprazolam extended release.
RU97116821A (ru) Способ лечения респираторных заболеваний
TH66360A3 (th) องค์ประกอบและวิธีการเกี่ยวกับการรักษาโรคภูมิแพ้
KR910005856A (ko) 호흡기 질환 치료용 제약 조성물

Legal Events

Date Code Title Description
EEIH Change in the person of patent owner
UEP Publication of translation of european patent specification

Ref document number: 0991479

Country of ref document: EP

REN Ceased due to non-payment of the annual fee
RZN Patent revoked